World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
80
Citations
32231
World Ranking
1599
National Ranking
798

Medicine

D-Index
81
Citations
32874
World Ranking
16429
National Ranking
8262

Lisa A. Beck publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lisa A. Beck sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 348 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lisa A. Beck D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lisa A. Beck sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lisa A. Beck is affiliated with the University of Rochester Medical Center in the United States. Their research primarily focuses on the field of Medicine with particular emphasis on Dermatology, Immunology and Allergy, Rheumatology, Physiology, and Immunology. The main topics addressed in their work include Dermatology and Skin Diseases, Allergic Rhinitis and Sensitization, Asthma and respiratory diseases, Urticaria and Related Conditions, Food Allergy and Anaphylaxis Research, Adrenal Hormones and Disorders, and IL-33, ST2, and ILC Pathways.

The scientist has published extensively, with significant contributions in several frequent publication venues. These include the Journal of the American Academy of Dermatology, Journal of Allergy and Clinical Immunology, Journal of Investigative Dermatology, British Journal of Dermatology, and Annals of Allergy Asthma & Immunology.

They have worked with multiple co-authors, some of the most frequent being Amy S. Paller, Eric L. Simpson, Mette Deleuran, Mark Boguniewicz, and Marjolein de Bruin-Weller.

Notable recent papers authored or co-authored by Lisa A. Beck include:

  • Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIII trials, 2020, British Journal of Dermatology
  • Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial, 2020, Journal of the American Academy of Dermatology
  • Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis, 2022, JID Innovations
  • The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis, 2020, Journal of the American Academy of Dermatology
  • Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis, 2020, American Journal of Clinical Dermatology

Best Publications

  • Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report

    Joshua A. Boyce;Amal Assa'ad;A. Wesley Burks;Stacie M. Jones

  • Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

    Eric L. Simpson;Thomas Bieber;Emma Guttman-Yassky;Lisa A. Beck

  • Atopic dermatitis

    Unknown

  • Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

    Lisa A. Beck;Diamant Thaçi;Jennifer D. Hamilton;Neil M. Graham

  • Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel

    Alkis Togias;Susan F. Cooper;Maria L. Acebal;Amal Assa'ad

  • Cytokine modulation of atopic dermatitis filaggrin skin expression

    Michael D. Howell;Byung Eui Kim;Peisong Gao;Audrey V. Grant

  • Tight junction defects in patients with atopic dermatitis.

    Anna De Benedetto;Nicholas M. Rafaels;Laura Y. McGirt;Andrei I. Ivanov

  • Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.

    Diamant Thaçi;Eric L Simpson;Lisa A Beck;Thomas Bieber

  • Activation of Airway Epithelial Cells by Toll-Like Receptor Agonists

    Quan Sha;Ai Q. Truong-Tran;James R. Plitt;Lisa A. Beck

  • Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia

    Megan L. Gill;Peter J. Grahn;Jonathan S. Calvert;Margaux B. Linde

  • Atopic dermatitis: A practice parameter update 2012

    Lynda Schneider;Stephen Tilles;Peter Lio;Mark Boguniewicz

  • Omalizumab-induced reductions in mast cell FcεRI expression and function

    Lisa A. Beck;Gregory V. Marcotte;Donald MacGlashan;Alkis Togias

  • Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.

    Eric L. Simpson;Amy S. Paller;Elaine C. Siegfried;Mark Boguniewicz

  • Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer

    J.W. Simons;E.M. Jaffee;C.E. Weber;H.J. Levitsky

  • Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

    Jennifer K Garrett;Sean C Jameson;Blythe Thomson;Margaret H Collins

  • Chemokines: Key Players in Innate and Adaptive Immunity

    Clemens Esche;Cristiana Stellato;Lisa A. Beck

  • Atopic dermatitis: a disease caused by innate immune defects?

    Anna De Benedetto;Ritesh Agnihothri;Laura Y. McGirt;Lora G. Bankova

  • Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

    Eric L. Simpson;J.‐P. Lacour;L. Spelman;R. Galimberti

  • Skin Barrier Disruption - A Requirement for Allergen Sensitization?

    Anna De Benedetto;Akiharu Kubo;Lisa A. Beck

  • Cytokine modulation of atopic dermatitis filaggrin skin expression.

    Unknown

  • Glucocorticosteroid inhibition of cytokine production: Relevance to antiallergic actions

    Lisa A. Schwiebert;Lisa A. Beck;Cristiana Stellato;Carol A. Bickel

  • Atopic dermatitis and asthma: Parallels in the evolution of treatment

    Lawrence F. Eichenfield;Jon M. Hanifin;Lisa A. Beck;Robert F. Lemanske

Frequent Co-Authors

Lynda C. Schneider
Lynda C. Schneider Boston Children's Hospital
Jon M. Hanifin
Jon M. Hanifin Oregon Health & Science University
Kathleen C. Barnes
Kathleen C. Barnes University of Colorado Denver
Donald Y.M. Leung
Donald Y.M. Leung National Jewish Health
Eric L. Simpson
Eric L. Simpson Oregon Health & Science University
Mark Boguniewicz
Mark Boguniewicz National Jewish Health
Nicholas Rafaels
Nicholas Rafaels University of Colorado Denver
Lawrence F. Eichenfield
Lawrence F. Eichenfield University of California, San Diego
Robert P. Schleimer
Robert P. Schleimer Northwestern University
Rasika A. Mathias
Rasika A. Mathias Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related online degrees such as psychiatric nurse practitioner programs can be a strategic choice. Many students seek online pmhnp programs with clinical placement, ensuring hands-on experience alongside theoretical learning. Clinical placements are crucial for building practical skills and easing the transition into healthcare roles.

Cost is another significant consideration. Prospective students often look for the cheapest pmhnp programs online to balance quality education with affordability. Financial accessibility can broaden opportunities for diverse candidates to advance their careers in immunology-related fields.

Career advancement within nursing can include paths like the Doctor of Nursing Practice (DNP). Understanding the doctor of nursing practice salary by state helps professionals make informed decisions about where to study or work, maximizing their earning potential in this specialized field.

Additionally, certification pathways such as the acute care nurse practitioner certification allow nurses to refine their expertise, especially when managing complex immunological cases. Transitioning between roles can expand career options and improve patient outcomes in immunology-related healthcare settings.

Best Scientists Citing Lisa A. Beck

Trending Scientists

Recently Published Articles